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Research
AbstrACt
Objectives To assess the effectiveness of orthotic devices 
for the management of instability of the knee in adults 
with a neuromuscular disorder or central nervous system 
disorder.
Design A systematic review of primary studies.
setting Community.
Participants Adults with a neuromuscular disorder or 
central nervous system disorder and impaired walking 
ability due to instability of the knee.
Interventions Orthoses with the clinical aim of controlling 
knee instability, for example, knee-ankle-foot orthoses, 
ankle-foot orthoses and knee orthoses or mixed design 
with no restrictions in design or material.
Primary and secondary outcome measures Condition-
specific or generic patient-reported outcome measures 
assessing function, disability, independence, activities of 
daily living, quality of life or psychosocial outcomes; pain; 
walking ability; functional assessments; biomechanical 
analysis; adverse effects; usage; patient satisfaction and 
the acceptability of a device; and resource utilisation 
data.
results Twenty-one studies including 478 patients were 
included. Orthotic devices were evaluated in patients 
with postpolio syndrome, poststroke syndrome, inclusion 
body myositis and spinal cord injury. The review included 
2 randomised controlled trials (RCTs), 3 non-randomised 
controlled studies and 16 case series. Most were small, 
single-centre studies with only 6 of 21 following patients 
for 1 year or longer. They met between one and five of nine 
quality criteria and reported methods and results poorly. 
They mainly assessed outcomes related to gait analysis 
and energy consumption with limited use of standardised, 
validated, patient-reported outcome measures. There was 
an absence of evidence on outcomes of direct importance 
to patients such as reduction in pain and falls.
Conclusions There is a need for high-quality research, 
particularly RCTs, of orthotic devices for knee instability 
related to neuromuscular and central nervous system 
conditions. This research should address outcomes 
important to patients. There may also be value in 
developing a national registry.
registration number systematic review PROSPERO 
(CRD42014010180).
IntrODuCtIOn
Instability can occur in any of the three 
anatomical planes of the knee: sagittal, 
coronal or transverse planes, and there 
are several mechanisms that may lead to 
knee instability in neuromuscular disorders 
(NMDs) and central nervous system (CNS) 
conditions. These include: weakness or over-
activity of any of the muscles that have a direct 
effect on the knee (knee extensors, knee 
flexors and gastrocnemius) and muscle weak-
ness or overactivity remote from the muscles 
directly affecting the knee due to secondary 
effects on posture (eg, alterations to the 
anterior progression of the ground reaction 
force under the foot or plantarflexor weak-
ness leading to uncontrolled dorsiflexion). In 
the case of CNS conditions, spasticity in the 
muscles around the knee can also cause knee 
instability (eg, spasticity in the gastrocnemius 
causes excessive plantarflexion in stance that 
shifts the ground reaction force anterior to 
strengths and limitations of this study
 ► The first systematic review addressing this question 
to systematically consider study quality.
 ► An extensive range of sources were searched to 
identify studies.
 ► It was difficult to be certain that knee instability 
was the main problem being treated in some of the 
studies.
 ► Due to poor reporting of the primary studies, it 
was not possible to extract outcome data in the 
standardised way planned in the protocol.
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the knee causing hyperextension).1 Knee instability can 
lead to pain, falls and a range of mobility issues for the 
individual.
Knee instability due to muscle weakness or ligamen-
tous laxity is often treated using orthoses with the func-
tional goals of improving walking and to protect, stabilise 
and improve function.2 Knee orthoses (KO) are often 
prescribed or in some cases a type of ankle-foot orthosis 
(AFO) known as a ground reaction AFO (GRAFO) may 
be provided. A GRAFO provides direct control of the 
ankle and foot, and indirect control of the knee and hip 
may be provided through optimising and normalising 
the alignment of the ground reaction force in relation 
to the knee joint throughout stance phase. A knee-ankle-
foot orthosis (KAFO) is usually prescribed when bracing 
with an AFO or KO is insufficient to adequately control 
knee instability and usually when control in more than 
one plane is required.2 Modern KAFOs tend to combine 
plastic and metal components: commonly polypropylene 
for calf and thigh shells and shoe inserts, aluminium, 
magnesium, titanium or steel for uprights and steel 
for joints.3 Variations exist in the orthotic knee joint 
design, locking and unlocking mechanism, type of knee 
pads and plane of control.3 A locked KAFO requires an 
altered gait to allow the individual’s foot to clear the 
ground in the swing phase of walking. Polycentric knee 
joints can be locked or unlocked and permit a more 
anatomical or natural knee motion, though have more 
two-joint axes and may require more maintenance and 
are therefore more expensive.3 Stance control knee joints 
have either a mechanical or microprocessor controlled 
knee joint that allows the knee to flex during the swing 
phase of walking, but locks during the stance phase of 
walking, when the knee is extended, allowing a more 
normal walking pattern. Other more extensive options 
include hip-knee-ankle-foot orthoses (HKAFO) origi-
nally designed for patients with higher level spinal cord 
dysfunction who might otherwise have been unable to 
walk.4 These include hip guidance orthoses (HGOs) and 
reciprocating gait orthoses (RGOs), which have different 
locking mechanisms.
We undertook a systematic review with the aim of 
assessing the evidence base for the effectiveness of 
orthotic devices for management of instability of the 
knee in adults who have NMD or a CNS disorder. This 
was part of a larger mixed-methods project undertaken to 
inform the development of a future substantive research 
question on the clinical and cost-effectiveness of different 
types of orthotic management of the knee in people with 
NMD or CNS disorders.1
MethODs
We undertook searches to identify studies assessing the 
effectiveness of orthotic devices for management of 
instability of the knee in adults who have NMD or a CNS 
disorder.
search methods for identification of studies
We searched the following databases from inception to 
November 2014: MEDLINE via Ovid, MEDLINE In-Pro-
cess via Ovid, Cumulative Index to Nursing & Allied 
Health via EBSCO, EMBASE via Ovid, PASCAL via Ebsco, 
Scopus, Science Citation Index (ISI Web of Knowledge), 
BIOSIS Previews, PEDro, Recal Legacy, Cochrane Data-
base of Systematic Reviews, Database of Abstracts of 
Reviews of Effects, Health Technology Assessment (HTA) 
database and Cochrane Central Register of Controlled 
Trials in The Cochrane Library, Conference Proceedings 
Citation Index-Science (ISI Web of Knowledge), Health 
Management Information Consortium via Ovid,  Clini-
calTrials. gov, WHO International Clinical Trials Registry 
Platform, National Technical Information Service and 
selected websites. There were no language or publication 
status restrictions. See online supplementary appendix 
1 for the MEDLINE (Ovid) search strategy, which was 
adapted for the other databases.
The reference lists of all included studies, any related 
systematic reviews and key background papers were 
checked to identify any further relevant studies.
eligibility criteria
Population
Adults (16 years or older) with NMD or CNS disorder 
and impaired walking ability due to instability of the knee 
were eligible for inclusion. Children were excluded.
Intervention
Orthoses with the clinical aim of controlling knee insta-
bility, for example, KAFO, AFO and KO or of mixed 
design with no restrictions in design, material, custom or 
prefabricated; type of knee joint or stance-control design 
(KAFO), or whether there was an electronic component. 
Studies evaluating the use of functional electrical stimula-
tion were excluded.
Studies were eligible provided the orthosis had been 
used in a real-life setting (ie, studies where the device had 
been solely used within a laboratory/experimental setting 
were excluded). Outcomes could be assessed in a labora-
tory or clinic setting provided participants had used the 
device in the community.
Comparator
Studies using any of the above orthoses as a comparator, 
including studies comparing different designs of the 
same orthosis or no intervention.
Study design
Randomised controlled trials (RCTs) and other study 
designs with and without a comparator group such as 
non-randomised controlled studies, before and after 
studies and case series were eligible for the review.
The following outcomes were of interest: condition-spe-
cific or generic patient-reported outcomes measures 
assessing function, disability, independence, activities of 
daily living, quality of life or psychosocial outcomes; pain; 
walking ability; functional assessments; biomechanical 
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analysis; adverse effects; usage; patient satisfaction and 
the acceptability of a device; and resource utilisation data.
Two researchers independently screened titles and 
abstracts and full papers to assess eligibility. Disagree-
ments were resolved through discussion and consultation 
with a third member of the project team if necessary. 
Authors were contacted if eligibility was uncertain from 
the information provided in the publication. There were 
no language restrictions.
Data extraction
Data were extracted by one researcher and checked 
by a second researcher with discrepancies resolved by 
discussion. Studies in languages other than English were 
extracted by a native speaker who was also a researcher 
and were checked by a second researcher for consistency 
only. Data were extracted using a piloted data extraction 
form. Multiple publications of the same study (linked 
papers) were extracted and reported as a single study. 
Between-group differences were extracted from studies 
with a comparator. We had planned to extract data to 
allow calculation of between group differences and CIs. 
However, due to the generally poor reporting of data, 
it was not possible to consistently do this across studies. 
Where data were available, these were extracted; where 
the appropriate data were not reported, the description 
of the results provided in the paper was extracted, and 
the lack of summary data was noted.
study quality
RCTs were assessed using the Cochrane risk of bias 
criteria.5 Non-randomised studies with a control group 
were assessed for external validity, performance bias, 
detection bias and selection bias/control of confounding 
based on eight criteria (gender, age, cause of muscle 
weakness, presence of sensory disturbance, whether the 
orthosis was used for proximal or distal muscle weakness, 
previous use of an orthosis, acclimatisation time and type 
of orthosis used). Case series were assessed using criteria 
adapted from the assessment of controlled studies and 
criteria used in a previous systematic review.6 Assessment 
of risk of bias was undertaken independently by two 
researchers (except for non-English language studies). 
Discrepancies were resolved by discussion.
The protocol was registered with PROSPERO in 
advance of undertaking the review (registration number 
CRD42014010180). Ethical approval was not required.
results
Overview of the evidence
A total of 4516 references were identified from the 
searches, and 21 studies of 478 patients (reported in 
25 publications) were included (figure 1). A full list of 
papers and reasons for exclusion is available from the 
authors. A substantial proportion were excluded (n=76) 
Figure 1 Study selection.
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because the orthosis was evaluated in a laboratory or clin-
ical setting without the participant using the device in the 
community. Three potentially relevant ongoing studies 
were identified: a before and after study,7 a case series8 
and an RCT.9
Table 1 provides a summary of study characteristics 
grouped by the four conditions covered by the included 
studies: postpolio, inclusion body myositis, poststroke and 
spinal cord injury. Two RCTs, 3 non-randomised studies 
with a control group and 16 case series were included. 
Sample sizes ranged from 5 to 67 participants and just 
fewer than half the studies had over 20 participants. 
The follow-up time was generally short, only six studies 
followed patients for 1 year or longer.
study quality
Both RCTs were assessed as having an unclear or high risk 
of bias for the majority of items on the Cochrane risk of 
bias tool (online supplementary file 2). Overall, the three 
non-randomised controlled studies were at risk of selection 
bias (online supplementary file 2). Ten of the 16 studies 
without a control group were prospective, while three were 
retrospective, and this aspect of the design was unclear for 
three. Overall, the 16 studies met between one and five of 
the nine quality criteria; only eight adequately described 
their inclusion criteria, and all were considered at risk of 
selection bias (online supplementary file 2). Poor reporting 
of study methods and results was a problem across all the 
study designs. Studies often made statements in the results 
section that were not backed up with numerical data. 
Where data were available, these were extracted; where the 
appropriate data were not reported, the description of the 
results provided in the paper was extracted, and the lack 
of summary data was noted in the data extraction tables, 
which are available in the HTA report.1
Outcomes
The most systematically assessed outcomes in the included 
studies were gait quality and energy consumption, assessed 
during clinic/laboratory visits (table 2). While several 
studies (table 2) reported patient satisfaction with the 
device and functionality (eg, how it impacted sitting in their 
wheelchair; the main ways in which they used the device), 
the results were predominantly reported in an anecdotal 
fashion, and it was not possible to assess how robustly the 
information had been collected. Despite our require-
ment that participants in studies had used their orthoses 
outside the clinic, only one study used a validated measure 
(Barthel Index) of patients’ ability to manage everyday 
activities of daily living outside the clinic setting10; and 
only two assessed quality of life using a validated measure 
(table 2). Generally, adverse effects such as skin damage or 
falls were not systematically reported. It cannot be inferred 
that there were few adverse events as authors did not specif-
ically mention that no adverse events were identified.
Patients with postpolio syndrome
Seven case series (n=143 patients) investigated types of 
carbon fibre KAFO (table 1). Three compared a new 
device to the one used previously by participants11–13; 
one compared using a device in stance control mode 
and locked mode (with the aim of replicating a tradi-
tional KAFO design)14; two before and after use of the 
orthosis15 16; and postintervention only in one study.17
Outcomes were sparsely reported. Five of the seven 
studies reported measures of patient satisfaction, although 
not in sufficient detail to assess the robustness of the eval-
uation.11–13 16 17 Three studies made a formal assessment 
of walking ability,11 12 14 and four assessed either energy 
consumption or particular muscle activity.11 12 14 15 Resource 
utilisation data were limited to assessment of device malfunc-
tion in four studies11–13 17 and cost in one study.12 Five studies 
failed to report adverse effects data or to mention that no 
adverse effects were identified.11 12 14–16
Inclusion body myositis
One case series study (n=9 patients) evaluated a stance 
control KAFO.18 Gait was assessed in the clinic with and 
without use of the device following 6 months of use. A 
questionnaire was designed by the investigators to elicit 
patient outcomes, but the results were not reported in 
full. No data were reported on resource utilisation or 
adverse effects.
Poststroke patients
Four studies (n=131 patients), one RCT,19 a cohort study,20 
and two case series,10 21 evaluated KAFOs and/or AFOs 
used for knee instability. One assessed a single outcome, 
gait with and without use of a carbon fibre KAFO.21 Two 
studies compared a thermoplastic KAFO with an AFO for 
knee instability: one compared patients who had recov-
ered sufficient control of knee activity to switch to an AFO 
with those who had not and therefore continued using 
a KAFO,10 effectively the comparison was between those 
who had recovered sufficient control of knee activity to 
switch to an AFO compared with those who had not; the 
second compared KAFO with AFO and normal adult 
gait.20 The RCT compared use of an AFO or KAFO with 
what was described as conventional rehabilitation (not 
reported in detail).19 The only patient-reported outcome 
assessed was usage.20 Three studies made a formal assess-
ment of walking ability,10 20 21 and two assessed other func-
tional abilities.10 19 None reported on resource utilisation 
data or adverse effects.
Patients with spinal cord injury
Nine studies (n=194 patients), one RCT,22 two controlled 
trials23 24 and six case series,25–30 evaluated HKAFOs. The 
RCT used a crossover design to compare Walkabout orthosis 
(WO) (Polymedic, Queensland, Australia) to an isocentric 
RGO (IRGO) (Center for Orthotics Design, Campbell, 
California, USA). There was a 2-month washout period of 
no orthoses use; the data were analysed as though from a 
parallel trial.22 There were two further studies of WO with 
no comparator.26 30 Two investigated a HGO, one with no 
comparator28 and one compared the HGO with a custom-
made RGO worn by the same patients in a crossover study.24 
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The remaining four studies investigated types of RGO, 
two with no comparator,25 29 one in comparison with RGO 
non-users27 and one compared three different types of 
orthoses (plus rehabilitation training) with rehabilitation 
training alone.23 Although each of the studies reported 
at least one patient-reported outcome, only one study 
reported using a validated scale (Barthel Index and Func-
tional Independence Measure), and due to lack of clarity in 
the analysis and reporting, it is unclear whether there were 
any between-group differences at follow-up in this study.23 
There were fewer objective assessments across the studies 
than for the other conditions.22 24 29 30 Resource utilisation 
data were limited to assessment of device malfunction24–26 28 
and cost.24 Two-thirds of studies did not address adverse 
effects.22–24 26 27 30
DIsCussIOn
Principal findings
The review identified a paucity of high-quality evidence 
assessing the effectiveness of orthotic devices for knee insta-
bility experienced by people with NMD and CNS condi-
tions. In addition to the very limited use of robust study 
designs, in particular RCTs, reporting was generally poor. 
For example, several studies made statements about find-
ings without presentation of supporting data. The evidence 
base consists of small, single-centre studies with outcome 
assessments that did not appear to have been undertaken 
independently of treating clinicians. Laboratory-based 
studies can provide useful insights about efficacy, particu-
larly during development of a device. However, the litera-
ture is dominated by laboratory evaluations of orthoses: 
76 studies were excluded because the evaluation of the 
orthosis did not include any use of the device by the patient 
in a non-clinic setting, and the most systematically assessed 
outcomes in the included studies focused on gait analysis 
and energy consumption. There was limited use of stan-
dardised, validated patient-reported outcome measures. In 
particular, there was an absence of evidence on outcomes 
that are reported by patients to be important to them such 
as reduction in pain, falls or trips, improved balance and 
stability and participation in paid employment, outdoor 
activities (such as gardening), family visits and social events.1 
In addition, fewer than one-third of the studies followed 
patients for a year or more. It is unlikely that studies of less 
than 1-year duration fully capture the effects of using the 
devices.
Given that patients report that orthotic devices prescribed 
for knee instability can play a crucial role in maintaining, 
promoting and enhancing physical and psychological 
health and well-being and participation in employment, 
family and social community activities,1 the evidence gaps 
identified by our review are significant and important. A 
factor that might contribute to this discrepancy in outcome 
measurement is current requirements for device regula-
tion; only evidence of performance and safety is required 
for medical devices associated with lower levels of risk to 
patients such as orthotics for knee instability. This may 
result in a lack of incentives to conduct primary research 
on efficacy and/or effectiveness.31
strengths and weaknesses of the study
We undertook systematic searches across an extensive range 
of sources for published, unpublished and ongoing studies. 
There were no language restrictions, and we included three 
studies published in Chinese19 23 29 and one in German.16 
We assessed the risk of bias in the included studies and used 
standard methods to reduce error and bias at key stages of 
the review process. Several studies provided a descriptive 
report of some outcomes with no numerical data. Due to 
the paucity of evidence, we extracted these reports in order 
to provide as clear a picture as possible of what informa-
tion is currently available. Arguably, this overestimates the 
amount of evidence that is available.
During study selection, it was often difficult to definitively 
determine whether the participants had knee instability. 
This was partly due to poor reporting and partly because 
knee instability was sometimes part of a more complex 
problem with stability and mobility and is not an explicit 
and well-defined clinical diagnosis. As a result, studies may 
have been included where it is arguable whether knee 
instability was the main problem and studies rejected that 
arguably do include people with knee instability. However, 
we would not expect that this would in any way change the 
overall conclusions of the review about the lack of high-
quality evidence or allow conclusions to be made about the 
effectiveness of specific devices.
An evidence base of small single-centre studies and inad-
equate study design is similar to that identified in other 
reviews of orthotic devices for different populations.32–34 
Also a systematic review of questionnaires used to assess 
patient satisfaction with orthoses for any limb found that 
63% of the 106 included papers used questionnaires devel-
oped for the specific study rather than validated measures, 
supporting our findings on this aspect of the evidence.35
unanswered questions and future research
There is a large gap in the evidence on the effectiveness 
of KAFOs, AFOs and other orthotic devices for managing 
knee instability related to NMD and CNS conditions. 
Robust research is required addressing outcomes that are 
important to patients. RCTs are the most robust way of 
assessing effectiveness, and a pragmatic trial that recog-
nises that provision of an orthotic device is a complex 
intervention would be appropriate.
There are a number of challenges for researchers and 
clinicians to consider when designing future studies, 
including: defining the target population and knee insta-
bility, the personalisation of treatment including customi-
sation of devices, the relative rarity of the problem within 
individual conditions and whether a trial including patients 
with knee instability with a range of NMD or CNS conditions 
would be generalisable. It may also be worth considering a 
national registry to systematically collect data on the ambu-
latory problem, devices provided, key elements of manage-
ment of the instability, factors that inform/determine the 
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process of matching patients to orthotic devices, collection 
of a core set of standardised and validated patient-reported 
outcome measures, data on use of the device and resource 
use. While registries do have limitations, this would be a 
major step change from the current evidence base in terms 
of increased rigour and generalisability and would create 
a population database and an infrastructure from which 
future RCTs could be undertaken. The evidence base in 
this field could also be improved through systematic devel-
opment of a core set of outcome measures (http://www. 
comet- initiative. org/). Future research regardless of study 
design should follow reporting standards (http://www. 
equator- network. org/).
COnClusIOns
There is a need for high-quality research, in particular 
RCTs, on the effectiveness of KAFOs, AFOs and other 
orthotic devices for managing knee instability related to 
NMD and CNS conditions. This research should address 
outcomes that are important to patients. There may also 
be value in developing a national registry.
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